Related Experiment Video
Updated: Apr 6, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Obesity Prevention in Scotland: A Policy Analysis Using the ANGELO Framework
John D Mooney1, Ruth Jepson, John Frank
1Department of Pharmacy, Health & Well-Being, University of Sunderland, Health Sciences Complex, City Campus, Sunderland, UK.
Obesity Facts
|August 1, 2015
Summary
The Scottish Government
Area of Science:
- Public Health
- Obesity Prevention Strategies
- Policy Analysis
Background:
- The Scottish Government's 'Route-Map Action Plan' outlines 62 obesity prevention policies.
- The ANGELO Framework (Analysis Grid for Environments Linked to Obesity) was employed to evaluate these policies.
Purpose of the Study:
- To assess the appropriateness and likely impact of proposed obesity prevention interventions.
- To analyze the balance of measures within the Scottish Government's action plan.
Main Methods:
- Interventions were categorized by domain (physical, economic, legislative, socio-cultural), scale (macro/micro), and focus (physical activity/diet).
- Two independent assessors categorized interventions, with a third resolving disagreements.
- The ANGELO Framework guided the assessment of policy domains and focus.
Main Results:
- Interventions were predominantly socio-cultural (37.1%) and physical environment-focused (33.1%).
- Legislative (21.8%) and economic (6.4%) interventions were less emphasized.
- Policy scale was balanced (51.8% macro-level), with a slight dietary focus (46.7%).
Conclusions:
- The prevalence of socio-cultural interventions contrasts with international evidence for effective obesity prevention.
- Legislative and economic interventions require greater emphasis for a balanced policy mix.
- The ANGELO framework is a valuable tool for monitoring obesity policy balance.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Models of Health Promotion and Illness Prevention II
2.3K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
The agent-host-environment model states that disease results...
2.3K
Models of Health Promotion and Illness Prevention I
3.1K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
3.1K
Drug Dosing: Obese Patients
343
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
394
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
287
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287

